Preserved lenalidomide efficacy in a recurrent isolated subcutaneous mantle cell lymphoma relapse

J BUON. 2018 Jan-Feb;23(1):273-274.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Angiogenesis Inhibitors / therapeutic use*
  • Female
  • Humans
  • Lenalidomide / therapeutic use*
  • Lymphoma, Mantle-Cell / diagnostic imaging
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / pathology
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology

Substances

  • Angiogenesis Inhibitors
  • Lenalidomide